Ali Hariri
Technik-/Wissenschafts-/F&E-Leiter bei ELOXX PHARMACEUTICALS, INC.
Profil
Ali Hariri is currently the Chief Medical Officer at Eloxx Pharmaceuticals, Inc. Prior to this, he worked as the Senior Head-Global Project at Genzyme Corp.
from 2016 to 2021.
He completed his undergraduate degree at The California State University and his doctorate at UC San Diego School of Medicine.
Aktive Positionen von Ali Hariri
Unternehmen | Position | Beginn |
---|---|---|
ELOXX PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 08.09.2021 |
Ehemalige bekannte Positionen von Ali Hariri
Unternehmen | Position | Ende |
---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.08.2021 |
Ausbildung von Ali Hariri
UC San Diego School of Medicine | Doctorate Degree |
The California State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ELOXX PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |